Analyst Speak:

“The Global Digital Pathology Market was valued at US$ 432.7 Mn in 2018 and is expected to grow at a significant CAGR over six years forecast period 2019-2025 owing to the increasing applications of digital pathology in drug development and companion diagnostics”

Precision Business Insights (PBI) in its report titled “Global Digital Pathology Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2018 and Forecast 2019-2025” assesses the market performance over six years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global digital pathology market was valued at US$ 432.7 Mn in 2018 and growing at a CAGR of XX% over the forecast period owing to owing to the increasing occurrence of chronic conditions is expected to surge clinical urgency to accept digital pathology to increase existing poor patient diagnostic imaging measures and to lessen high cost related with conventional diagnostics. Images can processed by computing algorithms, and can produce enhanced output. Moreover, the time required for the diagnosis also reduced ominously through digital pathology procedures. In addition, less probabilities of errors in observation as well as interpretation make it the digital pathology as most significant technology in the pathology. Furthermore, the investment in laboratory development and market penetration of key manufacturers are also expected to boost the growth of the market. However, lack of experienced staff and unfavorable reimbursement procedures are features that anticipated to obstruct the growth of the digital pathology market.

Avail Sample Report of the Market @ https://www.precisionbusinessinsights.com/request-sample?product_id=16095

Global digital pathology market segmented on the basis of product, type, application, end user, and region.

Human digital pathology segment accounted for higher revenue share

Based on type, global digital pathology market segmented Human Digital Pathology and Animal Digital Pathology. Human digital pathology market dominated the market growth owing to the growing number of cancer research activities and increasing partnerships between academic research institutes, universities, and pathology laboratories are driving the increased uptake of digital systems in human pathology.
North America holds leading position in Global Digital Pathology Market

PBI’s global digital pathology market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America is expected to account for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to increasing advancements in technology and surge in R&D investments. Europe is anticipated to be another main market for the digital pathology due to existence of large number of patient population. Asia Pacific is projected to raise at the substantial growth rate due to growing investments to adopt new technologies and devices, and the existence of untapped opportunities. Increasing number of cancer patients in the region is expected to drive the growth of the market over the forecast years.
Recent Developments in the Global Digital Pathology Market

 In March 2017, Danaher Corporation parented with Leeds Hospital to improve productivity and workflow
 In June 2016, Royal Philips, acquired PathXL, a pathology, image-based analysis firm to develop integrated tools targeting applications in computational biology, education, workflow solutions, and image analytics.

For More Information @ https://www.precisionbusinessinsights.com/market-reports/global-digital-pathology-market/

Key player’s profiles in the report are Perkin Elmer, Inc. (U.S.), Olympus Corporation (Japan), AstraZeneca plc (Definiens AG) (U.K.), Sectra AB (Sweeden), GE Healthcare (U.K.), Inspirata Co. (U.S.), The Danaher Corporation (U.S.), Koninklijke Philips N.V (Netherlands), F. Hoffmann-La Roche AG (Ventana Medical Systems) (Switzerland), Digipath Co. (U.S.), Carl Zeiss AG (Germany), 3D-Histech Ltd. (Hungary), Yokogawa Electronic Corporation (Japan), Quorum Technologies Inc. (Canada) and Hamamatsu Photonics K.K. (Japan) to name a few.

Detailed Segmentation

By Product
o Scanners
o Software
o Communication Systems
o Storage Systems

By Type
o Human Digital Pathology
o Animal Digital Pathology

By Application
o Tele consultation
o Disease Diagnosis
o Drug Discovery

By End User
o Hospitals
o Pharmaceutical companies
o Academic institutes

Geography

o North America
• US
• Canada
o Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
o Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific
o Latin America
• Brazil
• Mexico
• Argentina
• Venezuela
• Rest of Latin America
o Middle East and Africa (MEA)
• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights